Erico Masala

674 total citations
16 papers, 437 citations indexed

About

Erico Masala is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Erico Masala has authored 16 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Hematology and 4 papers in Genetics. Recurrent topics in Erico Masala's work include Acute Myeloid Leukemia Research (8 papers), Epigenetics and DNA Methylation (3 papers) and Blood disorders and treatments (3 papers). Erico Masala is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Epigenetics and DNA Methylation (3 papers) and Blood disorders and treatments (3 papers). Erico Masala collaborates with scholars based in Italy, France and United States. Erico Masala's co-authors include Valeria Santini, Francesca Buchi, Alessandro Sanna, Antonella Gozzini, Ana Valencia, Alberto Bosi, Kristen Meldi, Daniela Gioia, Tingting Qin and María E. Figueroa and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Clinical Cancer Research.

In The Last Decade

Erico Masala

16 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erico Masala Italy	11	254	250	86	59	39	16	437
Erik L. Bao United States	10	61 0.2×	314 1.3×	53 0.6×	71 1.2×	68 1.7×	14	538
Patrick G. Knott Australia	9	144 0.6×	111 0.4×	96 1.1×	125 2.1×	39 1.0×	11	535
Martin Wahlestedt Sweden	11	271 1.1×	364 1.5×	53 0.6×	141 2.4×	50 1.3×	15	560
Yiran Meng United Kingdom	9	293 1.2×	199 0.8×	91 1.1×	212 3.6×	41 1.1×	20	494
Kelly A. Soltysiak United States	12	201 0.8×	254 1.0×	87 1.0×	55 0.9×	36 0.9×	36	482
Christopher Hoover United States	11	98 0.4×	131 0.5×	27 0.3×	91 1.5×	8 0.2×	13	344
Claude Hattab France	15	178 0.7×	192 0.8×	68 0.8×	59 1.0×	17 0.4×	28	461
Seka Lazare Netherlands	6	200 0.8×	245 1.0×	79 0.9×	140 2.4×	62 1.6×	8	448
Claire Dobson United Kingdom	10	159 0.6×	349 1.4×	40 0.5×	100 1.7×	29 0.7×	14	513
Sanmay Bandyopadhyay United States	12	73 0.3×	147 0.6×	74 0.9×	168 2.8×	26 0.7×	16	450

Countries citing papers authored by Erico Masala

Since Specialization

Citations

This map shows the geographic impact of Erico Masala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erico Masala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erico Masala more than expected).

Fields of papers citing papers by Erico Masala

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erico Masala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erico Masala. The network helps show where Erico Masala may publish in the future.

Co-authorship network of co-authors of Erico Masala

This figure shows the co-authorship network connecting the top 25 collaborators of Erico Masala. A scholar is included among the top collaborators of Erico Masala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erico Masala. Erico Masala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Ward, Grace, Kathy L. McGraw, Farnoosh Abbas‐Aghababazadeh, et al.. (2021). Oxidized mitochondrial DNA released after inflammasome activation is a disease biomarker for myelodysplastic syndromes. Blood Advances. 5(8). 2216–2228. 28 indexed citations

Mattiucci, Domenico, Elisa Rossi, Erico Masala, et al.. (2020). Serum Inflamma-miR Signature: A Biomarker of Myelodysplastic Syndrome?. Frontiers in Oncology. 10. 595838–595838. 1 indexed citations

Masala, Erico, Serena Pillozzi, Alessandro Sanna, et al.. (2018). Severe hypoxia selects hematopoietic progenitors with stem cell potential from primary Myelodysplastic syndrome bone marrow cell cultures. Oncotarget. 9(12). 10561–10571. 5 indexed citations

Cheloni, Giulia, Erico Masala, Nathalie M. Mazure, et al.. (2017). The Leukemic Stem Cell Niche: Adaptation to “Hypoxia” versus Oncogene Addiction. Stem Cells International. 2017. 1–8. 17 indexed citations

Cluzeau, Thomas, Kathy L. McGraw, Brittany Irvine, et al.. (2017). Pro-inflammatory proteins S100A9 and tumor necrosis factor-α suppress erythropoietin elaboration in myelodysplastic syndromes. Haematologica. 102(12). 2015–2020. 32 indexed citations

Masala, Erico, et al.. (2017). Resistance to Azacitidine is Determined at Cellular Level by Lower Expression of Nucleoside Metabolizing Enzymes. Leukemia Research. 55. S90–S91. 1 indexed citations

Meldi, Kristen, Tingting Qin, Francesca Buchi, et al.. (2015). Specific molecular signatures predict decitabine response in chronic myelomonocytic leukemia. Journal of Clinical Investigation. 125(5). 1857–1872. 129 indexed citations

Cluzeau, Thomas, Kathy L. McGraw, Brittany Irvine, et al.. (2015). The Proinflammatory Protein S100A9 Suppresses Erythropoietin Elaboration in Patients with Myelodysplastic Syndromes. Blood. 126(23). 355–355. 2 indexed citations

Meldi, Kristen, Omar Abdel‐Wahab, Tingting Qin, et al.. (2014). Molecular Determinants of Decitabine Response in Chronic Myelomonocytic Leukemia. Blood. 124(21). 4644–4644. 1 indexed citations

10.

Valencia, Ana, Erico Masala, Alessandro Di Martino, et al.. (2013). Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine. Leukemia. 28(3). 621–628. 70 indexed citations

11.

Buchi, Francesca, Erico Masala, Ana Valencia, et al.. (2013). Redistribution of H3K27me3 and acetylated histone H4 upon exposure to azacitidine and decitabine results in de-repression of the AML1/ETO target gene IL3. Epigenetics. 9(3). 387–395. 15 indexed citations

12.

Spinelli, Elena, Roberto Caporale, Francesca Buchi, et al.. (2012). Distinct Signal Transduction Abnormalities and Erythropoietin Response in Bone Marrow Hematopoietic Cell Subpopulations of Myelodysplastic Syndrome Patients. Clinical Cancer Research. 18(11). 3079–3089. 25 indexed citations

13.

Margheri, Martina, Alessia Tani, Daniele Nosi, et al.. (2012). Combined effects of melatonin and all-trans retinoic acid and somatostatin on breast cancer cell proliferation and death: Molecular basis for the anticancer effect of these molecules. European Journal of Pharmacology. 681(1-3). 34–43. 43 indexed citations

14.

Buchi, Francesca, Elena Spinelli, Erico Masala, et al.. (2012). Proteomic analysis identifies differentially expressed proteins in AML1/ETO acute myeloid leukemia cells treated with DNMT inhibitors azacitidine and decitabine. Leukemia Research. 36(5). 607–618. 17 indexed citations

15.

Masala, Erico, Ana Valencia, Francesca Buchi, et al.. (2012). Hypermethylation of Wnt antagonist gene promoters and activation of Wnt pathway in myelodysplastic marrow cells. Leukemia Research. 36(10). 1290–1295. 13 indexed citations

16.

Tonini, Raffaella, et al.. (2001). Calcium Protects Differentiating Neuroblastoma Cells during 50Hz Electromagnetic Radiation. Biophysical Journal. 81(5). 2580–2589. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact